CS MEDICA
CS MEDICA postpones its Annual Report to February 24, 2024 and the Annual General Meeting to February 29, 2024
REG
CS MEDICA A/S, a MedTech company that focuses on treating pain, autoimmune diseases, and stress-related disorders with therapeutic CBD/cannabinoids, announces the rescheduling of its Annual Report to Wednesday, February 14, 2024. Consequently, the Annual General Meeting is also rescheduled and will now occur on Thursday, February 29, 2024.
| Datum | 2023-11-29, kl 11:52 |
| Källa | Cision |
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 10 000 unika besökare per månad. Vår discord har över 5000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!